- Home
- / Mochida Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Mochida Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥3.4 K
2024-10-29
Market Capitalization
¥121.1 B
2024-10-28
Revenue
¥105.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 106.8B | 109.6B | 101.8B | 103.0B | 110.2B | 103.3B | 102.9B | 105.2B |
| Cost of goods sold | 50.6B | 52.6B | 47.1B | 45.5B | 47.9B | 45.5B | 48.0B | 48.4B |
| Gross profit | 56.2B | 57.1B | 54.6B | 57.5B | 62.2B | 57.8B | 54.9B | 56.7B |
| Gross profit margin, % | 52.6% | 52.1% | 53.7% | 55.9% | 56.5% | 56.0% | 53.3% | 53.9% |
| Operating expense total | 41.9B | 43.6B | 43.1B | 42.8B | 45.2B | 46.6B | 46.3B | 45.7B |
| Depreciation and amortization | 2.6B | 3.9B | 2.7B | 2.7B | 2.8B | 2.7B | 2.8B | 2.9B |
| EBITDA | 14.3B | 13.5B | 11.5B | 14.7B | 17.1B | 11.2B | 8.4B | 10.4B |
| EBITDA margin, % | 13.4% | 12.3% | 11.3% | 14.3% | 15.5% | 10.8% | 8.2% | 9.9% |
| EBIT | 11.7B | 11.0B | 5.9B | 11.6B | 13.6B | 8.8B | 5.8B | 7.7B |
| EBIT margin, % | 11.0% | 10.0% | 5.8% | 11.3% | 12.4% | 8.5% | 5.6% | 7.3% |
| Interest income | 3.0M | 3.0M | 3.0M | 3.0M | 2.0M | 2.0M | 2.0M | 29.0M |
| Interest expense | 3.0M | 1.0M | 2.0M | 3.0M | ||||
| Pre tax profit | 12.1B | 11.6B | 6.3B | 11.9B | 14.6B | 9.0B | 6.2B | 8.1B |
| Income tax expense | 3.1B | 3.2B | 1.7B | 3.3B | 4.0B | 2.4B | 1.6B | 2.4B |
| Net Income | 9.0B | 8.4B | 4.6B | 8.6B | 10.6B | 6.6B | 4.5B | 5.7B |